Your browser doesn't support javascript.
loading
Near-Haploid B-Cell Acute Lymphoblastic Leukemia in a Patient with Rubinstein-Taybi Syndrome.
Kurtz, Kristen J; Tallis, Eran; Marcogliese, Andrea N; Pulivarthi, Rao H; Potocki, Lorraine; Stevens, Alexandra M.
Affiliation
  • Kurtz KJ; Department of Pediatrics, Section of Hematology/Oncology, Baylor College of Medicine and Texas Children's Hospital, Houston, Texas, USA.
  • Tallis E; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA.
  • Marcogliese AN; Department of Pathology & Immunology, Baylor College of Medicine, Houston, Texas, USA.
  • Pulivarthi RH; Department of Pediatrics, Section of Hematology/Oncology, Baylor College of Medicine and Texas Children's Hospital, Houston, Texas, USA.
  • Potocki L; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA.
  • Stevens AM; Department of Pediatrics, Section of Hematology/Oncology, Baylor College of Medicine and Texas Children's Hospital, Houston, Texas, USA.
Pediatr Hematol Oncol ; 39(8): 747-754, 2022 Nov.
Article in En | MEDLINE | ID: mdl-35275800
ABSTRACT
Rubinstein-Taybi syndrome (RSTS) is a rare disorder characterized by developmental delay, short stature, dysmorphic facies and skeletal abnormalities. RSTS has been linked to a variety of malignant and benign tumors, but the frequency and characteristics of RSTS-related neoplasms remain unclear. We describe a unique case of near haploid B-cell lymphoblastic leukemia (B-ALL) in a 6-year-old girl with RSTS who harbors a likely pathogenic variant in CREBBP. Somatic CREBBP variants are enriched in some subsets of ALL; however, germline variants have not been previously described in childhood leukemia and may represent an underrecognized predisposition to malignancy. Our patient's disease responded poorly to conventional chemotherapy and relapsed following a complete remission achieved with CD19 CAR T cell therapy. We propose that the constitutional CREBBP variant may have played a significant role in the leukemia's resistance to chemotherapy and this patient's poor response to therapy.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Rubinstein-Taybi Syndrome / Burkitt Lymphoma / Precursor Cell Lymphoblastic Leukemia-Lymphoma Limits: Child / Female / Humans Language: En Journal: Pediatr Hematol Oncol Journal subject: HEMATOLOGIA / NEOPLASIAS / PEDIATRIA Year: 2022 Document type: Article Affiliation country: Estados Unidos

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Rubinstein-Taybi Syndrome / Burkitt Lymphoma / Precursor Cell Lymphoblastic Leukemia-Lymphoma Limits: Child / Female / Humans Language: En Journal: Pediatr Hematol Oncol Journal subject: HEMATOLOGIA / NEOPLASIAS / PEDIATRIA Year: 2022 Document type: Article Affiliation country: Estados Unidos